Author: Edison Ong; Mei U Wong; Anthony Huffman; Yongqun He
Title: COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning Document date: 2020_3_21
ID: ld0vo1rl_4
Snippet: In this study, we first surveyed the existing coronavirus vaccine development status, and 98 then applied the Vaxign RV and Vaxign-ML approaches to predict COVID-19 protein 99 candidates for vaccine development. We identified six possible adhesins, including the structural 100 protein and non-structural proteins (including nsp3) using reverse vaccinology and machine 107 learning, we proposed and discussed a cocktail vaccine strategy, for rational.....
Document: In this study, we first surveyed the existing coronavirus vaccine development status, and 98 then applied the Vaxign RV and Vaxign-ML approaches to predict COVID-19 protein 99 candidates for vaccine development. We identified six possible adhesins, including the structural 100 protein and non-structural proteins (including nsp3) using reverse vaccinology and machine 107 learning, we proposed and discussed a cocktail vaccine strategy, for rational COVID (Table 2) . 128 more typically mild HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1. The sequence 138 conservation suggested the potential of N protein as a candidate for the cross-protective vaccine 139 against SARS and MERS. The N protein was also evaluated and used for vaccine development 140 (Table 2 ). The N protein packs the coronavirus RNA to form the helical nucleocapsid in virion 141 assembly. This protein is more conserved than the S protein and was reported to induce an 142 immune response and neutralize coronavirus infections 23 . However, a study also showed the 143 linkage between N protein and severe pneumonia or other serious liver failures related to the 144 pathogenesis of SARS 24 . 145 146 Six adhesive proteins in SARS-CoV-2 identified as potential vaccine targets 147
Search related documents:
Co phrase search for related documents- adhesive protein and non structural protein: 1
- adhesive protein and potential vaccine: 1, 2
- cocktail vaccine and coronavirus infection: 1
- cocktail vaccine and immune response: 1
- cocktail vaccine and potential vaccine: 1
- coronavirus infection and development status: 1, 2
- coronavirus infection and helical nucleocapsid: 1
- coronavirus infection and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- coronavirus infection and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- coronavirus infection and non structural protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- coronavirus vaccine and development status: 1, 2
- coronavirus vaccine and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- coronavirus vaccine and non structural protein: 1, 2, 3, 4, 5, 6, 7
- cross protective vaccine and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9
- development status and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- helical nucleocapsid and immune response: 1
- immune response and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- immune response and non structural protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- liver failure and non structural protein: 1, 2
Co phrase search for related documents, hyperlinks ordered by date